Serum CEA, as a broad‐spectrum tumor marker, may increase in a variety of tumors, including gastrointestinal malignancies, lung cancer, and breast cancer.17, 18 Previous researches had found that MTC can also secrete CEA, and the increased level of serum CEA in MTC patients was synchronous with Ctn.9, 19 This study also showed that there was significant correlation between serum CEA and Ctn in MTC patients (rct‐cea = 0.871). This evidence concerns the gene CEACAM5 and breast cancer.